COVIDApp as an Innovative Strategy for the Management and Follow-Up of COVID-19 Cases in Long-Term Care Facilities in Catalonia: Implementation Study.


Journal

JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345

Informations de publication

Date de publication:
17 07 2020
Historique:
received: 07 06 2020
accepted: 06 07 2020
revised: 26 06 2020
pubmed: 7 7 2020
medline: 31 7 2020
entrez: 7 7 2020
Statut: epublish

Résumé

The coronavirus disease (COVID-19) pandemic has caused an unprecedented worldwide public health crisis that requires new management approaches. COVIDApp is a mobile app that was adapted for the management of institutionalized individuals in long-term care facilities. The aim of this paper is to report the implementation of this innovative tool for the management of long-term care facility residents as a high-risk population, specifically for early identification and self-isolation of suspected cases, remote monitoring of mild cases, and real-time monitoring of the progression of the infection. COVIDApp was implemented in 196 care centers in collaboration with 64 primary care teams. The following parameters of COVID-19 were reported daily: signs/symptoms; diagnosis by reverse transcriptase-polymerase chain reaction; absence of symptoms for ≥14 days; total deaths; and number of health care workers isolated with suspected COVID-19. The number of at-risk centers was also described. Data were recorded from 10,347 institutionalized individuals and up to 4000 health care workers between April 1 and 30, 2020. A rapid increase in suspected cases was seen until day 6 but decreased during the last two weeks (from 1084 to 282 cases). The number of confirmed cases increased from 419 (day 6) to 1293 (day 22) and remained stable during the last week. Of the 10,347 institutionalized individuals, 5,090 (49,2%) remained asymptomatic for ≥14 days. A total of 854/10,347 deaths (8.3%) were reported; 383 of these deaths (44.8%) were suspected/confirmed cases. The number of isolated health care workers remained high over the 30 days, while the number of suspected cases decreased during the last 2 weeks. The number of high-risk long-term care facilities decreased from 19/196 (9.5%) to 3/196 (1.5%). COVIDApp can help clinicians rapidly detect and remotely monitor suspected and confirmed cases of COVID-19 among institutionalized individuals, thus limiting the risk of spreading the virus. The platform shows the progression of infection in real time and can aid in designing new monitoring strategies.

Sections du résumé

BACKGROUND
The coronavirus disease (COVID-19) pandemic has caused an unprecedented worldwide public health crisis that requires new management approaches. COVIDApp is a mobile app that was adapted for the management of institutionalized individuals in long-term care facilities.
OBJECTIVE
The aim of this paper is to report the implementation of this innovative tool for the management of long-term care facility residents as a high-risk population, specifically for early identification and self-isolation of suspected cases, remote monitoring of mild cases, and real-time monitoring of the progression of the infection.
METHODS
COVIDApp was implemented in 196 care centers in collaboration with 64 primary care teams. The following parameters of COVID-19 were reported daily: signs/symptoms; diagnosis by reverse transcriptase-polymerase chain reaction; absence of symptoms for ≥14 days; total deaths; and number of health care workers isolated with suspected COVID-19. The number of at-risk centers was also described.
RESULTS
Data were recorded from 10,347 institutionalized individuals and up to 4000 health care workers between April 1 and 30, 2020. A rapid increase in suspected cases was seen until day 6 but decreased during the last two weeks (from 1084 to 282 cases). The number of confirmed cases increased from 419 (day 6) to 1293 (day 22) and remained stable during the last week. Of the 10,347 institutionalized individuals, 5,090 (49,2%) remained asymptomatic for ≥14 days. A total of 854/10,347 deaths (8.3%) were reported; 383 of these deaths (44.8%) were suspected/confirmed cases. The number of isolated health care workers remained high over the 30 days, while the number of suspected cases decreased during the last 2 weeks. The number of high-risk long-term care facilities decreased from 19/196 (9.5%) to 3/196 (1.5%).
CONCLUSIONS
COVIDApp can help clinicians rapidly detect and remotely monitor suspected and confirmed cases of COVID-19 among institutionalized individuals, thus limiting the risk of spreading the virus. The platform shows the progression of infection in real time and can aid in designing new monitoring strategies.

Identifiants

pubmed: 32629425
pii: v6i3e21163
doi: 10.2196/21163
pmc: PMC7373378
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21163

Informations de copyright

©Patricia Echeverría, Miquel Angel Mas Bergas, Jordi Puig, Mar Isnard, Mireia Massot, Cristina Vedia, Ricardo Peiró, Yolanda Ordorica, Sara Pablo, María Ulldemolins, Mercé Iruela, Dolors Balart, José María Ruiz, Jordi Herms, Bonaventura Clotet Sala, Eugenia Negredo. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 17.07.2020.

Références

JAMA. 2020 Mar 23;:
pubmed: 32203977
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
J Nutr Health Aging. 2020;24(5):461-462
pubmed: 32346680
J Am Geriatr Soc. 2020 May;68(5):912-917
pubmed: 32212386
J Am Med Dir Assoc. 2020 May;21(5):569-571
pubmed: 32179000
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
JMIR Public Health Surveill. 2020 Apr 2;6(2):e18810
pubmed: 32238336
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
J Am Geriatr Soc. 2020 May;68(5):939-940
pubmed: 32162679
J Microbiol Immunol Infect. 2020 Jun;53(3):447-453
pubmed: 32303480
Lancet. 2020 Mar 14;395(10227):859
pubmed: 32171399
J Am Geriatr Soc. 2020 May;68(5):918-921
pubmed: 32243567
J Telemed Telecare. 2020 Jun;26(5):309-313
pubmed: 32196391
BMJ. 2020 Mar 12;368:m998
pubmed: 32165352

Auteurs

Patricia Echeverría (P)

Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Lluita contra la Sida Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Miquel Angel Mas Bergas (MA)

Direcció Clínica Territorial Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Jordi Puig (J)

Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Lluita contra la Sida Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Mar Isnard (M)

Direcció Clínica Territorial Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Mireia Massot (M)

Servei d'Atenció Primària Vallès Occidental, Direcció Atenció Primària Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Cristina Vedia (C)

Servei d'Atenció Primària Barcelonès Nord Maresme, Direcció Atenció Primària Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Ricardo Peiró (R)

Servei d'Atenció Primària Barcelonès Nord Maresme, Direcció Atenció Primària Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Yolanda Ordorica (Y)

Servei d'Atenció Primària Vallès Oriental, Direcció Atenció Primària Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Sara Pablo (S)

Direcció Atenció Primària Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

María Ulldemolins (M)

Servei d'Atenció Primària Barcelonès Nord Maresme, Direcció Atenció Primària Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Mercé Iruela (M)

Servei d'Atenció Primària Vallès Oriental, Direcció Atenció Primària Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Dolors Balart (D)

Direcció Atenció Primària Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

José María Ruiz (JM)

Lluita contra la Sida Foundation, Digital Health Department, Doole Health S.L., Badalona, Spain.

Jordi Herms (J)

Lluita contra la Sida Foundation, Digital Health Department, Doole Health S.L., Badalona, Spain.

Bonaventura Clotet Sala (B)

Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Lluita contra la Sida Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
AIDS Research Institute-IRSICAIXA, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.
Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic - Central University of Catalonia, Barcelona, Spain.

Eugenia Negredo (E)

Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Lluita contra la Sida Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic - Central University of Catalonia, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH